Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOP1630 in Dry Eye Syndrome
NCT03088605Phase 2Completed
- Start
- Feb 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TOP1630 in dry eye syndrome (DED). Started Feb 2017; status: completed.
02
Drugs
TOP1630
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03088605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03088605.